 |
| Click to visit the Hepatitis B Foundation |
CANCER DIGEST – June 9, 2014 – An anti-viral treatment for hepatitis B may turn out to
prevent liver cancer according to a new study of 2600 patients treated for the disease. In a first-of-its-kind analysis those treated with
antiviral therapy had a significantly lower occurrence of liver cancer during a
five-year follow up period. Overall, 3 percent of the patients developed liver
cancer during the study period. But patients who received antiviral
therapy were 60 percent less likely to develop liver cancer than untreated
patients. “The results
of this study allow us to reassure our patients that we are not just treating
their viral levels, but that antiviral therapy may actually lessen their chance
of developing liver cancer,” said the study’s lead investigator, Henry Ford
Health System’s Stuart C. Gordon, M.D. The finding was published in the May
issue of Clinical Gastroenterology and
Hepatology.
No comments:
Post a Comment